\begin{table}[h!]
    \caption {Examples of Targeted Molecular therapies receiving marketing approval by the US Food and Drug Administration (FDA) \citep{neidleCancerDrugDesign2014}.}
    \centering
    \footnotesize
    \begin{tabular}{@{}clcc@{}}
    \toprule
    Year & Therapeutic & Drug type & Primary molecular target(s) \\
    \midrule
    1998 & Trastuzumab & Antibody  & ERBB2      \\
    1999 & Exemestane  & Small molecule & Aromatase \\
         & Erlotinib & Small molecule & EGFR\\ 
    2005 & Sorafenib & Small molecule & VEGFR, C-RAF,PDGFR \\
    2006 & Vorinostat & Small molecule & HDAC \\
         & Sunitinib & Small molecule & multikinase \\
    2007 & Nilotinib & Small molecule & BCR-ABL, c-KIT, PDGFR\\ 
         & Temsirolimus & Small molecule & mTOR\\
    2012 & Bosutinib&Small molecule & BCR-ABL,SRC \\  
        &Axitinib &Small molecule &VEGFR1,2,3 \\ 
        &Enzalutamide &Small molecule &Androgen receptor \\ 
    \bottomrule
    \end{tabular}
    \label{table2.1}
\end{table}